Vertex Pharmaceuticals Incorporated (VRTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$450.78
Day's range
$461.26

Vertex Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
CAPITAL WORLD INVESTORS 02/11/2026 25.51 M $11.57 B   -1.55% 9.98%
VANGUARD GROUP INC 01/29/2026 24.11 M $10.93 B   -0.46% 9.49%
BLACKROCK, INC. 02/12/2026 23.75 M $10.77 B   6.74% 9.35%
CAPITAL RESEARCH GLOBAL INVESTORS 02/11/2026 17.32 M $7.85 B   4.61% 6.77%
STATE STREET CORP 02/13/2026 11.69 M $5.30 B   0.72% 4.60%
JPMORGAN CHASE & CO 02/11/2026 6.04 M $2.74 B   -6.14% 2.36%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 5.98 M $2.70 B   0.14% 2.36%
CAPITAL INTERNATIONAL INVESTORS 02/11/2026 4.73 M $2.15 B   0.95% 1.85%
ALLIANCEBERNSTEIN L.P. 02/17/2026 4.50 M $2.04 B   -0.58% 1.76%
LOOMIS SAYLES & CO L P 02/12/2026 4.03 M $1.83 B   -2.15% 1.58%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 3.82 M $1.73 B   -19.91% 1.49%
VICTORY CAPITAL MANAGEMENT INC 02/13/2026 3.36 M $1.52 B   49.35% 1.31%
JENNISON ASSOCIATES LLC 01/30/2026 3.25 M $1.47 B   -5.95% 1.27%
NORGES BANK 02/10/2026 3.18 M $1.44 B   100.00% 1.24%
MORGAN STANLEY 02/13/2026 3.12 M $1.41 B   0.38% 1.23%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 3.00 M $1.36 B   3.94% 1.17%
BANK OF AMERICA CORP /DE/ 02/17/2026 2.94 M $1.33 B   3.40% 1.16%
CLEARBRIDGE INVESTMENTS, LLC 02/11/2026 2.86 M $1.30 B   8.10% 1.12%
NORTHERN TRUST CORP 02/17/2026 2.58 M $1.17 B   -1.84% 1.01%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 2.28 M $1.03 B   -25.13% 0.89%
AMERIPRISE FINANCIAL INC 02/17/2026 2.26 M $1.03 B   -0.58% 0.89%
JANUS HENDERSON GROUP PLC 02/17/2026 2.22 M $1.01 B   4.85% 0.87%
FMR LLC 02/17/2026 2.21 M $1.00 B   -33.03% 0.87%
INVESCO LTD. 02/19/2026 2.15 M $975.94 M   2.66% 0.85%
LEGAL & GENERAL GROUP PLC 02/09/2026 1.97 M $893.17 M   0.91% 0.77%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.86 M $842.90 M   1.60% 0.73%
DEUTSCHE BANK AG\ 02/11/2026 1.77 M $801.94 M   10.52% 0.69%
GOLDMAN SACHS GROUP INC 03/25/2026 1.75 M $795.25 M   18.15% 0.69%
BANK OF NEW YORK MELLON CORP 02/10/2026 1.53 M $692.55 M   -2.65% 0.60%
AMUNDI 02/17/2026 1.30 M $591.25 M   16.55% 0.51%
ROYAL BANK OF CANADA 02/17/2026 1.19 M $541.54 M   0.07% 0.47%
WCM INVESTMENT MANAGEMENT, LLC 02/09/2026 1.13 M $512.34 M   -1.82% 0.44%
EDGEWOOD MANAGEMENT LLC 02/12/2026 1.06 M $480.60 M   -28.74% 0.41%
NUVEEN, LLC 02/12/2026 1.04 M $472.58 M   -3.28% 0.41%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 945.66 K $428.73 M   20.68% 0.37%
WINSLOW CAPITAL MANAGEMENT, LLC 02/12/2026 887.64 K $405.10 M   100.00% 0.35%
BARCLAYS PLC 02/13/2026 847.76 K $384.34 M   14.18% 0.33%
AMERICAN CENTURY COMPANIES INC 02/13/2026 848.64 K $384.74 M   88.93% 0.33%
ASSENAGON ASSET MANAGEMENT S.A. 01/09/2026 832.85 K $377.58 M   9.05% 0.33%
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN 02/17/2026 803.77 K $364.40 M   -40.08% 0.31%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 752.43 K $342.20 M   -4.93% 0.29%
WELLS FARGO & COMPANY/MN 02/13/2026 741.81 K $336.31 M   3.41% 0.29%
SWISS NATIONAL BANK 02/12/2026 702.60 K $318.53 M   -5.09% 0.27%
BELLEVUE GROUP AG 02/17/2026 681.12 K $308.79 M   34.66% 0.27%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 02/13/2026 669.81 K $303.72 M   46.78% 0.26%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 01/23/2026 654.47 K $296.71 M   -6.59% 0.26%
HSBC HOLDINGS PLC 03/20/2026 630.29 K $285.89 M   -1.11% 0.25%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 593.95 K $269.27 M   55.81% 0.23%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 589.10 K $267.07 M   -1.29% 0.23%
MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 02/03/2026 566.23 K $256.01 M   3.90% 0.22%

Vertex Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 2267 institutional investors and hedge funds held shares of Vertex Pharmaceuticals, Inc.. The most heavily invested institutionals were:

Bank of New York Mellon Corp: 1.59 M

Nuveen, LLC: 1.08 M

HSBC HOLDINGS PLC: 655,443

UBS Group AG: 630,618

Sumitomo Mitsui Trust Holdings, Inc.: 614,448

Assenagon Asset Management S.A.: 537,248

92.21% of Vertex Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 301.89 M shares in the last 24 months. This purchase volume represents approximately $139.13 B in transactions.